Settlement talks have ended between the Federal Trade Commission and Amgen over the latter’s proposed acquisition of Horizon Therapeutics, according to a report by Bloomberg.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,